Back to User profile » Dr Rengui Zhou

Papers published by Dr Rengui Zhou:


Combination of Osimertinib and Anlotinib May Overcome the Resistance Mediated by in cis EGFR T790M-C797S in NSCLC: A Case Report

Zhou R, Song L, Zhang W, Shao L, Li X, Li X

OncoTargets and Therapy 2021, 14:2847-2851

Published Date: 28 April 2021

Studies on the Safety and Efficacy of Pyrotinib in the Treatment of HER2- Positive Advanced Solid Tumors Excluding Breast Cancer

Yin Y, Yang H, Liu Z, Tan J, Zhu C, Chen M, Zhou R, Wang L, Qian J

Cancer Management and Research 2020, 12:13479-13487

Published Date: 30 December 2020